FDA Adverse Event Injury Summary report: N

GYNECARE TVT OBURATOR SYSTEM

MDR report key: 3150645 · Received June 6, 2013

Report

Report Number
2210968-2013-10017
Event Type
Injury
Date Received
June 6, 2013
Report Date
November 11, 2016
Manufacturer
ETHICON INC.
Product Code
OTN
PMA / PMN Number
K033568
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
RI, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). A REVIEW OF THE BATCH MANUFACTURING RECORDS WAS CONDUCTED AND THE BATCH MET ALL FINISHED GOODS RELEASE CRITERIA.

Additional Manufacturer Narrative · 1

(B)(4). NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY.

Additional Manufacturer Narrative · 1

IT WAS REPORTED THAT FOLLOWING MESH INSERTION THE PATIENT EXPERIENCED PAIN, URINARY PROBLEMS, RECURRENCE, DYSPAREUNIA AND VAGINAL SCARRING. (B)(4).

Additional Manufacturer Narrative · 1

(B)(4): IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE AND MESH WAS IMPLANTED ALONG WITH CONCURRENT VAGINAL VAULT REPAIR AFTER HYSTERECTOMY AND LEFT BUTTOCK SKIN TAG REMOVAL DUE TO SUI, CYSTOCELE AND RECTOCELE.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE ON (B)(6) 2005; MESH WAS IMPLANTED CONCURRENTLY WITH ANTERIOR POSTERIOR COLPORRHAPHY, SACRO-SPINOUS LIGAMENT VAULT SUSPENSION WITH MESH AND SKIN TAG REMOVAL TO TREAT STRESS URINARY INCONTINENCE, CYSTOCELE, RECTOCELE, AND VAGINAL VAULT PROLAPSE AFTER HYSTERECTOMY. IT IS REPORTED THAT THE PATIENT EXPERIENCED PAIN, EROSION OF HER INTERNAL TISSUES, AND SHE HAS UNDERGONE ADDITIONAL SURGERIES AND REVISIONARY PROCEDURES. NO ADDITIONAL INFORMATION IS PROVIDED AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
250637 GYNECARE TVT OBURATOR SYSTEM MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC OTN ETHICON INC. UNK 1332541

Patients

Seq Age Sex Outcome Treatment
1 63 YR Required Intervention